A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

NCT00700063 ·Status: COMPLETED ·Phase: PHASE2

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

NCT01836367 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis

NCT01214564 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel

NCT00427050 ·Status: COMPLETED ·Phase: PHASE2

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

NCT00375739 ·Status: COMPLETED ·Phase: PHASE2

A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand

NCT00544297 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers

NCT00850681 ·Status: COMPLETED ·Phase: PHASE1

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

NCT00989313 ·Status: COMPLETED

A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers

NCT00850811 ·Status: COMPLETED ·Phase: PHASE1

Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

NCT01600014 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

NCT02361216 ·Status: COMPLETED ·Phase: PHASE3

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses

NCT00107965 ·Status: COMPLETED ·Phase: PHASE2

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

NCT00239135 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

NCT01998984 ·Status: COMPLETED ·Phase: PHASE2

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

NCT00659893 ·Status: COMPLETED ·Phase: PHASE1

PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology

NCT01387711 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks

NCT02090465 ·Status: COMPLETED

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

NCT01926496 ·Status: COMPLETED ·Phase: PHASE4

PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy

NCT01449513 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis

NCT02242747 ·Status: COMPLETED ·Phase: NA

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp

NCT01541553 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions

NCT02124239 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

NCT02716714 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Actinic Keratoses (AK) on the Face

NCT02411851 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005

NCT00544258 ·Status: COMPLETED ·Phase: PHASE1